Triglyceride Threshold for Intensive Lipid-Lowering Therapy in Acute Hyper-Triglyceridemic Pancreatitis: A...

Area of Science:

• Endocrinology
• Gastroenterology
• Critical Care Medicine

Background:

• Hypertriglyceridemic acute pancreatitis (HTG-AP) poses a significant clinical challenge.
• The prognostic value of early triglyceride (TG) reduction in HTG-AP is debated.
• Understanding TG level associations with clinical outcomes is crucial for effective management.

Purpose of the Study:

• To evaluate the association between admission TG levels and early TG goal achievement with clinical outcomes in HTG-AP patients.
• To identify potential TG thresholds related to disease severity and progression.
• To inform clinical practice regarding early lipid-lowering therapy in HTG-AP.

Main Methods:

• Retrospective analysis of 345 HTG-AP patients.
• Definition of early TG goal achievement: TG ≤ 5.65 mmol/L within 72 hours.
• Ordinal logistic regression used to analyze associations between TG parameters and disease severity (Revised Atlanta Classification).

Main Results:

• No significant differences in pancreatic necrosis, hospital stay, or mortality between early TG goal-achieved and non-achieved groups.
• Highest admission TG levels did not correlate with the most severe disease.
• TG levels between 11.3-56.5 mmol/L were associated with lower odds of severe disease compared to TG > 90.4 mmol/L.

Conclusions:

• Early achievement of TG goals within 72 hours did not improve clinical outcomes in HTG-AP.
• Admission TG levels, particularly ≥ 56.5 mmol/L, may indicate a higher risk for disease progression.
• Aggressive early lipid-lowering therapy requires further validation; TG thresholds need more research.